THTX (Theratechnologies) Short-Term Capital Lease Obligation : $0.22 Mil (As of Feb. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Theratechnologies Short-Term Capital Lease Obligation?

Theratechnologies's Short-Term Capital Lease Obligation for the quarter that ended in Feb. 2025 was $0.22 Mil.

Theratechnologies's quarterly Short-Term Capital Lease Obligation declined from Aug. 2024 ($0.46 Mil) to Nov. 2024 ($0.38 Mil) and declined from Nov. 2024 ($0.38 Mil) to Feb. 2025 ($0.22 Mil).

Theratechnologies's annual Short-Term Capital Lease Obligation declined from Nov. 2022 ($0.48 Mil) to Nov. 2023 ($0.42 Mil) and declined from Nov. 2023 ($0.42 Mil) to Nov. 2024 ($0.38 Mil).

Theratechnologies Short-Term Capital Lease Obligation Historical Data

The historical data trend for Theratechnologies's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Short-Term Capital Lease Obligation Chart

Theratechnologies Annual Data

Trend

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.43

0.46

0.48

0.42

0.38

Theratechnologies Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.43	0.44	0.46	0.38	0.22

Theratechnologies Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Theratechnologies Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TQ80:Germany TH:Canada

Address

2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.